ACPU
LLY icon

Arrowgrass Capital Partners (US)’s Eli Lilly LLY Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-177,600
Closed -$15M – 321
2017
Q4 		$15M Buy
177,600
+175,554
+8,580% +$14.9M 0.15% 176
2017
Q3 		$17.5M Hold
2,046
– – 0.13% 192
2017
Q2 		$16.8M Buy
2,046
+506
+33% +$41.3K 0.13% 211
2017
Q1 		$13M Buy
1,540
+1,145
+290% +$91.7K 0.13% 206
2016
Q4 		$2.9M Buy
+395
New +$29.4K 0.03% 319
2016
Q2 		– Sell
-500
Closed -$3.6M – 432
2016
Q1 		$3.6M Hold
500
– – 0.04% 219
2015
Q4 		$4.21M Buy
+500
New +$41.5K 0.05% 170
2013
Q4 		– Sell
-200,000
Closed -$10.1M – 178
2013
Q3 		$10.1M Buy
+200,000
New +$10.5M 0.38% 60

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s LLY Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) reduced its Eli Lilly (LLY) stake by 76% in Q4 2019, selling an estimated $2.01M and leaving 5,389 shares worth $708K. The position accounts for 0.19% of the portfolio, ranked #49.

Arrowgrass Capital Partners (US) first reported a position in LLY in Q3 2013 and has held it in 9 quarters since. The position peaked at $6.69M in Q1 2017. 1,673 funds tracked by Wall St. Rank hold LLY as of Q4 2019.

  • Arrowgrass Capital Partners (US) held 5,389 shares of Eli Lilly worth $708K as of Q4 2019.
  • Arrowgrass Capital Partners (US) sold 17,323 Eli Lilly shares in Q4 2019, an estimated $2.01M.
  • Eli Lilly made up 0.19% of Arrowgrass Capital Partners (US)'s portfolio in Q4 2019, its #49 holding.
  • Arrowgrass Capital Partners (US) first reported a position in Eli Lilly in Q3 2013 and has held it in 9 quarters since.
  • Arrowgrass Capital Partners (US)'s Eli Lilly position peaked at $6.69M in Q1 2017.
  • 1,673 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.